Source:http://linkedlifedata.com/resource/pubmed/id/10341281
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
21
|
| pubmed:dateCreated |
1999-5-27
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0028-4793
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
27
|
| pubmed:volume |
340
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1672-4
|
| pubmed:dateRevised |
2001-11-26
|
| pubmed:meshHeading |
pubmed-meshheading:10341281-Anti-HIV Agents,
pubmed-meshheading:10341281-DNA, Viral,
pubmed-meshheading:10341281-HIV Infections,
pubmed-meshheading:10341281-HIV-1,
pubmed-meshheading:10341281-RNA, Viral,
pubmed-meshheading:10341281-Transcription, Genetic,
pubmed-meshheading:10341281-Viral Load,
pubmed-meshheading:10341281-Virus Replication
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
Residual HIV-1 disease in the era of highly active antiretroviral therapy.
|
| pubmed:publicationType |
Editorial,
Comment
|